Treatment Regimen

Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, according to new research.

Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, according to randomized trial p

District Court Judge Raymond Voet of Ionia County, Mich., was never a big fan of specialty courts. Hug-a-thug, he sometimes referred to sobriety and drug courts that promise drunken drivers and drug offenders leniency if they abide by a lengthy and strict

( American Society for Radiation Oncology ) Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years afte

( University of Pennsylvania School of Medicine ) Patients being treated for chronic hepatitis C become less likely to take their medications over time, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Since